The Priority Review

Tag

apraclonidine

1 story

  1. Approvals

    FDA approves Brytly, a nonprescription eye drop for eye redness

    The FDA approved Brytly, apraclonidine ophthalmic solution 0.125%, for relief of eye redness due to minor irritations. The approval is the first nonprescription eye drop containing apraclonidine and is available to adults and children 12 years of age and older.